Rui Li

11PUBLICATIONS
79CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsPrimary health careApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 03, 2026
Signaling Mutations Negate the Favorable Impact of NPM1 Mutations in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With VEN/HMA.

|Jun 25, 2026
Embedding a primary care provider in sickle cell teams improves sickle cell care.

|May 22, 2026
Clinical outcomes of CD3xCD20 bispecific antibodies in patients with central nervous system involvement by lymphoma.

|May 21, 2026
Clonal Hematopoiesis Rates in a Recurrent Venous Thrombosis Population: A Prospective Pilot Study.

|Feb 03, 2026
Clinical outcomes of older patients with NPM1-mutated or KMT2A-rearranged AML before menin inhibitors: a Beat AML report.

Joshua F Zeidner, Jayanshu Jain, Rina Li Welkie

|Jun 12, 2025
Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed NPM1-Mutated or KMT2A-Rearranged AML.

Joshua F Zeidner, Tara L Lin, Rina Li Welkie

Pageof 2

Frequent Collaborators

4 joint publications

Joshua F Zeidner

3 joint publications

Tara L Lin

3 joint publications

Alice S Mims

3 joint publications

Elie Traer